Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

cardiovascular · Mechanism Report

Does the LDLR rs6511720 GG genotype align with higher LDL cholesterol?

The LDLR rs6511720 T allele is associated with lower LDL cholesterol, while the GG genotype lacks this LDL-lowering variant and aligns with higher LDL-family cholesterol.

PlausibleJuly 30, 202610 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

LDLR rs6511720 T allele is associated with lower LDL cholesterol, so GG lacks this LDL-lowering variant and can align with higher LDL-family cholesterol

laying out figure…
0 of 3 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

This claim says the rs6511720 T allele in LDLR is linked to reduced LDL cholesterol, whereas GG means the protective variant is absent. The mechanism described is increased LDL receptor expression and LDL clearance with the T allele, so non-carriers have the usual baseline clearance and higher circulating LDL. The graph also frames LDL cholesterol as part of the pathway connected to coronary heart disease risk.

Verified conclusion

The LDLR gene plays a critical role in cellular cholesterol homeostasis by encoding the low-density lipoprotein receptor responsible for clearing LDL particles from circulation. Variations within this gene, specifically the rs6511720 single nucleotide polymorphism, significantly influence individual lipid profiles.

Clinical evidence

  • T Allele Protective Effects: Large-scale genome-wide association studies (GWAS) demonstrate that each copy of the minor T allele of rs6511720 is associated with a reduction of approximately 7 to 8 mg/dL in circulating LDL cholesterol (LDL-C), which translates to a lower risk of coronary heart disease.
  • GG Genotype and Elevated Lipids: Individuals with the GG genotype lack this protective variant. Consequently, they display higher baseline LDL-C levels, with cohort data showing GG homozygotes (particularly females) have elevated odds of presenting with higher LDL-C tiers (e.g., ≥130 mg/dL) compared to GT or TT carriers.

Mechanistic explanations

  • Enhancer Activity: The rs6511720 T allele functions as a functional intronic enhancer. It alters the DNA sequence to strengthen the binding of transcription factors, such as serum response element (SRE) binding proteins, in hepatocytes.
  • Receptor Expression and Clearance: This enhanced binding boosts LDLR promoter activity and transcription. The resulting increase in cell-surface LDL receptor expression facilitates more efficient hepatic clearance of circulating LDL particles. Non-carriers (GG genotype) lack this transcription-boosting mechanism, leading to standard baseline clearance and higher circulating levels of LDL-family cholesterol.

Bottom line

  • The LDLR rs6511720 T allele is a well-established regulatory variant that lowers LDL-C by increasing receptor expression. Individuals with the GG genotype lack this protective enhancer variant, which naturally aligns them with higher baseline LDL-C levels and a standard, unreduced risk profile for coronary heart disease.

References

  1. Identification of the Functional Variant(s) that Explain ... — pubmed.ncbi.nlm.nih.gov ↗
  2. Table 3. Meta-analysis of GWAS–identified LDL-C SNPs. — pmc.ncbi.nlm.nih.gov ↗
  3. Online Mendelian Inheritance in Man (OMIM) — omim.org ↗
  4. Identification of the Functional Variant(s) that Explain the Low-Density Lipoprotein Receptor (LDLR) GWAS SNP rs6511720 Association with Lower LDL-C and Risk of CHD — dx.plos.org ↗
  5. Identification of the Functional Variant(s) that Explain the Low ... — journals.plos.org ↗
  6. Sex-specific effect of the LDL-receptor rs6511720 ... — inase.org ↗
  7. HEART HEALTH | LDLR (rs6511720) — plexusdx.com ↗
  8. Pleiotropic cardiometabolic effects of the LDLR rs6511720 T allele: an evaluation of genetic risk across metabolic states. — linkinghub.elsevier.com ↗
  9. Pleiotropic cardiometabolic effects of the LDLR rs6511720 T allele: an evaluation of genetic risk across metabolic states - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  10. Lifelong Reduction of LDL-Cholesterol Related to a Common Variant in the LDL-Receptor Gene Decreases the Risk of Coronary Artery Disease—A Mendelian Randomisation Study — journals.plos.org ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesAre F2-isoprostanes biomarkers of lipid peroxidation and does oxidized LDL contribute to atherosclerosis?→Plausible10 sourcesDo hs-CRP, Lp-PLA2, and myeloperoxidase reflect different cardiovascular risk signals?→